Prothena Corporation plc PRTA is a bio medical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on PRTA's earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Prothena Corporation could be a solid choice for investors.
Current Quarter Estimates for PRTA
In the past 30 days, 1 estimate has gone higher for Prothena Corporation with no downward revisions in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 41 cents a share 30 days ago, to an earnings of 81 cents today, a move of 297.6 %.
Current Year Estimates for PRTA
Meanwhile, Prothena Corporation's current year figures are also looking quite promising, with 2 estimates moving higher in the past month, compared to no downward revision. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of $1.96 per share 30 days ago to a loss of 71 cents per share today, an increase of 63.8%.
Bottom Line
The stock has also started to move higher lately, adding 47.3% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #3 (Hold) stock to profit in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
PROTHENA CP PLC PRTA: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsThese positive earnings estimate revisions suggest that analysts are becoming more optimistic on PRTA's earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Prothena Corporation could be a solid choice for investors.
Current Quarter Estimates for PRTA
In the past 30 days, 1 estimate has gone higher for Prothena Corporation with no downward revisions in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 41 cents a share 30 days ago, to an earnings of 81 cents today, a move of 297.6 %.
Current Year Estimates for PRTA
Meanwhile, Prothena Corporation's current year figures are also looking quite promising, with 2 estimates moving higher in the past month, compared to no downward revision. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of $1.96 per share 30 days ago to a loss of 71 cents per share today, an increase of 63.8%.
Bottom Line
The stock has also started to move higher lately, adding 47.3% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #3 (Hold) stock to profit in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
PROTHENA CP PLC PRTA: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
